ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) Institutional Ownership

CUSIP: G6333L101

13F Institutional Holders and Ownership History from Q2 2018 to Q4 2025

Type / Class
Equity / Stock
Symbol
ITRM on Nasdaq
Price per share
$0.33
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
223,362
Total reported value
$74,826
% of total 13F portfolios
0%
Share change
+29,583
Value change
+$9,910
Number of holders
4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP G6333L101?
CUSIP G6333L101 identifies ITRM - ITERUM THERAPEUTICS PLC SHS NEW - Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 4 institutional investors reported holding 223,362 shares of ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM).

Institutional Holders of ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 223,362 $74,826 +$9,910 $0.33 4
2025 Q3 193,779 $129,831 +$46,415 $0.67 4
2025 Q2 87,613 $87,175 +$17,512 $1.00 3
2025 Q1 70,013 $86,116 +$12,218 $1.23 2
2024 Q4 60,045 $106,280 +$106,023 $1.77 4
2024 Q3 145 $158 +$86 $1.09 3
2024 Q2 66 $76 -$59 $1.15 1
2024 Q1 104 $161 -$28 $1.55 2
2023 Q4 104 $205 $1.97 2
2023 Q3 104 $83 $0.80 2
2023 Q2 104 $112 $1.08 2
2023 Q1 104 $104 -$196 $1.00 2
2022 Q4 344 $289 -$168,719 $0.84 3
2022 Q3 110,950 $242,000 -$3,224,180 $1.66 4
2022 Q2 5,867,944 $1,174,760 +$138,592 $0.20 27
2022 Q1 5,076,439 $1,800,325 -$575,766 $0.36 26
2021 Q4 6,552,309 $2,566,448 +$47,246 $0.39 33
2021 Q3 6,173,145 $3,447,914 -$4,397,065 $0.56 34
2021 Q2 11,509,393 $25,951,620 +$11,192,929 $2.31 38
2021 Q1 7,971,838 $11,187,538 +$2,107,908 $1.41 43
2020 Q4 6,982,600 $6,904,000 +$987,740 $0.99 18
2020 Q3 4,974,883 $5,223,000 -$1,420,677 $1.05 12
2020 Q2 6,157,552 $7,327,000 -$4,519,811 $1.19 9
2020 Q1 7,036,339 $19,069,000 -$20,970 $2.71 14
2019 Q4 7,066,427 $31,799,000 -$3,824,521 $4.50 13
2019 Q3 5,976,908 $34,616,000 -$644,226 $5.90 18
2019 Q2 6,085,777 $41,871,000 +$217,624 $6.88 18
2019 Q1 6,053,922 $48,078,000 -$1,661,106 $8.03 18
2018 Q4 6,298,907 $31,557,000 -$268,230 $5.01 21
2018 Q3 6,346,311 $42,261,000 -$2,696,101 $6.70 20
2018 Q2 6,644,262 $71,614,000 +$71,614,083 $10.89 23